Authored By: Sarah
26 Nov 2021

Botanical And Plant-Derived Drugs Market | Market Highlights and Insights to Recovery from COVID-19
Market Forecast and Growth Projections 2021-2025

The Global botanical and plant-derived drugs market is expected to grow by $ 14.4 bn, accelerating at a CAGR of over 7.11% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus.


For a snapshot of our exhaustive research analysis and insights:  Request for Our Free Sample Report


Botanical And Plant-Derived Drugs Market: Market Segments and Growth Forecasts

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

  • The report segments the market by Type (Plant-derived drugs and Botanical drugs) and Geography (Asia, Europe, North America, and ROW). Each market segment is analyzed for past performance leading to future growth projections based on current market scenario.
  • 45% of the market growth will originate from Asia during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Botanical And Plant-Derived Drugs Market size.

Botanical And Plant-Derived Drugs Market Size to Grow by $ 14.4 bn through 2021-2025 | Leading Segments and Market Trends

Botanical And Plant-Derived Drugs Market: Trends, Drivers, Challenges

Our report helps market players to discover the various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will provide clients with all the information they would require for designing a growth strategy for their business.

  • Increase in government initiatives will be a significant factor in driving the growth of the Botanical And Plant-Derived Drugs Market.
  • Another factor that will boost the market will be the Limitations associated with conventional drugs.
  • Low acceptance among physicians is a challenge that needs to be overcome to persist on the path to growth and recovery from the impact of the pandemic.

Botanical And Plant-Derived Drugs Market: Vendor Analysis

  • The market is fragmented.
  • The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
  • Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pierre Fabre SA, and Sanofi SA are some of the major market participants.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of over 7.11%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 14.4 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    Increase in government initiatives will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    Asia, Europe, North America, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    45% growth will originate from Asia

     
  6. Who are the leading market vendors?
    The leading vendors in this market are Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pierre Fabre SA, and Sanofi SA

     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Plant-derived drugs and Botanical drugs) and Geography (Asia, Europe, North America, and ROW)

Botanical And Plant-Derived Drugs Market Size to Grow by $ 13.67 bn through 2020-2024 | Forecast and Trend Analysis

Technavio has been monitoring the botanical and plant-derived drugs market and it is expected to grow by $ 13.67 bn, accelerating at a CAGR of almost 7% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking View Free Sample Report

Botanical And Plant-Derived Drugs Market: Emerging Trends to Impact Market Growth

Transformation of regulatory landscape in us to emerge as a key trend in the industrial botanical and plant-derived drugs market. This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will enable clients to assess their play in the market and plan for growth opportunities.

Botanical And Plant-Derived Drugs Market Size to Grow by $ 14.4 bn through 2021-2025 | Leading Segments and Market Trends

Botanical And Plant-Derived Drugs Market: Vendor Analysis

The market is fragmented due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Johnson & Johnson, Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pfizer Inc., Pierre Fabre SA, and Sanofi are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Technavio custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

For more insights into this market:Download a Free Sample Report

The Global Botanical and Plant-Derived Drugs Market is expected to grow by USD13.67 billion accelerating at a CAGR of over 6% during the forecast period. Although the healthcare industry is expected to witness positive growth as a result of COVID-19, the impact of the pandemic on the market in focus is expected to remain NEUTRAL. Technavio evaluates the market with a detailed investigation into the market forces, emerging trends, and growth drivers. It also provides competitive benchmarking to equip clients with actionable insights that will help them navigate through the current market scenario. Preview our latest report with COVID-19 Impact Analysis

"The demand for herbal medicines is rising and these medicines are gaining prominence in the healthcare sector. For instance, in China, herbal medicines play a significant role in the treatment of severe acute respiratory syndrome. Governments across many countries such as China, India, the US, and Nigeria and the World Health Organization (WHO) have made considerable research investments in herbal medicines", says senior research analyst for the Health Care Industry at Technavio.

Botanical And Plant-Derived Drugs Market Size to Grow by $ 14.4 bn through 2021-2025 | Leading Segments and Market Trends

Botanical And Plant-Derived Drugs Market: TypeSegment Highlights

  • Type Segmentation: Plant-derived drugs and Botanical drugs
  • Plant-derived drugs segment dominated the market in 2019, however, market growth in the plant-derived drugs segment will be slower than the growth of the market in the botanical drugs segment. 
  • The increasing need for effective drugs for the treatment of chronic disorders such as cancer and diabetes has fueled the demand for plant-derived drugs.

Botanical And Plant-Derived Drugs Market: Competitive Analysis

  • The Botanical and Plant-Derived Drugs Market is fragmented due to the presence of several vendors.
  • Market vendors focused on developing advanced interventional cardiology products, market expansion, innovations, and expansion of distribution networks.
  • Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Johnson & Johnson, Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pfizer Inc., Pierre Fabre SA, and Sanofi are some of the major market participants. Although the increase in government initiatives will offer immense growth opportunities, the low acceptance among physicians will challenge the growth of the market participants. 

Technavio provides custom research reports with detailed insights on the impact of COVID-19 with respect to the industry, region, and supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations. Download a Free Sample Report 

Read News Read Less
Interested in this report?
Get your sample now!
Technavio